drugset / Trial / NCT06388720
The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy
Phase 2
Recruiting
82 enrolled
National Cancer Center, Korea
Chonnam National University Hospital · collabKorea University Anam Hospital · collabPusan National University Hospital · collabSamsung Medical Center · collabSeoul National University Bundang Hospital · collabSeoul St. Mary's Hospital · collabSeverance Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study is to evaluate the effectiveness and safety of mitomycin-c and gemcitabine sequential instillation in BCG unresponsive high risk non-muscle invasive bladder cancer patients.
Timeline
- Start
- 2024-11-19
- Primary completion
- 2027-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 2000 mg | Other |
| Subject | Mitomycin C | Other / unclassified | 40 mg | Other |